Is Nasus Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Nasus Pharma Ltd (NSRX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nasus Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nasus Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Nasus Pharma Ltd?

Muslim investors may consider investing in Nasus Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nasus Pharma Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Nasus Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nasus Pharma Ltd updated?

The Shariah compliance status of Nasus Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nasus Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nasus Pharma Ltd?

You can check the latest Shariah compliance status of Nasus Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

NSRX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 28, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Nasus Pharma Ltd (NSRX)

Based on 8 analysts giving stock ratings to Nasus Pharma Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Nasus Pharma Ltd. Stock Analysis NSRX

United States Health Care Nano Cap Report: 2025 Annual

Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. The company employs 7 full-time employees The company went IPO on 2025-08-13. The firm conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The firm's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.

Key Statistics of Nasus Pharma Ltd (NSRX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.82$3.04

Today's Open

$2.90

Volume

33.15K

P/E Ratio (TTM)

52 Week Range

$1.98$9.99

Market Cap

24.81M

Avg. Volume

126.36K

Dividend Yield

Financial Metrics & Statements of Nasus Pharma Ltd (NSRX)

FAQ's for Nasus Pharma Ltd (NSRX)

According to Musaffa’s Shariah screening methodology, Nasus Pharma Ltd (NSRX) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.